HYDERABAD, India, March 13, 2024 /PRNewswire/ — Cyient, a global Intelligent Engineering and Technology Solutions company, has announced that it has signed a multiyear services agreement with Airbus for Cabin and Cargo Engineering.
Following this agreement, Cyient has been selected by Airbus for the development of a part of its cabin ‘Intelligent Core Management Platform’ (iCMP). These systems focus on enabling faster software updates, easy and rapid customization, and proliferation of digital services in Cabin. Cyient has been working with Airbus, supporting the future-ready Cabins to deliver state-of-the-art services requiring new technologies and significant data flow volumes.
“We thank Airbus for their confidence in our capabilities and partnering to work on their key future technology development programs. Cyient is committed to growing this partnership with Airbus to greater heights. We look forward to leveraging our technology expertise to support Airbus in their pursuit of transforming in-flight communication and diagnostics systems,” said Karthikeyan Natarajan, Executive Director and CEO, Cyient.
About Cyient:
Cyient (Estd: 1991, NSE: CYIENT) partners with over 300 customers, including 40% of the top 100 global innovators, to deliver intelligent engineering and technology solutions for a digital, autonomous, and sustainable future. As a company, Cyient is committed to Designing a culturally inclusive, socially responsible, and environmentally sustainable Tomorrow Together with our stakeholders.
For more information, please visit www.cyient.com
Follow news about the company at @Cyient
|
Gowtham Uyalla Kaizzen PR |
Phalguna Hari jandhyala Cyient |
ข่าวที่เกี่ยวข้อง
- Coremail Showcases at GITEX Asia 2026: Advancing Enterprise Communication with AI-Native Secure Email
- Spingence and Digital Base Unveil Secure Internal Data-Connected AI Platform at AI EXPO Tokyo 2026
- TGT Technology Group Shines at Japan IT Week Spring 2026, Empowering Japanese Enterprises with Global Smart Connectivity Through vSIM and eSIM
- Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)
